News Archive | Page 14 of 23 | Lexaria Bioscience Corp.

News

New LOI Signed to Out-License Lexaria’s Technology

Kelowna, BC / August 30, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”) has entered a new letter of intent (LOI) to license its proprietary absorption and…

Lexaria Enters Loan Agreement

Kelowna, BC / July 25, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is entering a loan agreement for the principal amount of US$50,000. The term of the agreement…

Definitive Technology Licensing Agreement Reached

Kelowna, BC / May 20, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is very pleased to announced it has entered into the definitive agreement first announced in a…

Lexaria Confirms Name Change

Kelowna, BC / May 9, 2016 / Lexaria Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) provides the following update. Lexaria confirms that the name change to Lexaria Bioscience Corp has occurred and…